J. van den Berg - Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 6 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

LBA31 Neoadjuvant nivolumab plus relatlimab (anti-LAG3) in locally advanced MMR-deficient colon cancers: The NICHE-3 study

Y.L. Verschoor,J. van den Berg, S. Balduzzi, J.C. van Blijderveen, S. Oosterling,P. Burger, T. Aukema, T. Vogten, S. Dokter, R. Beets-Tan, A.V. Lent, G. Beets,

Annals of Oncology (2023): S1270-S1270

引用0浏览0引用

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study

M. Chalabi, Y. L. Verschoor,J. Van De Haar,J. van den Berg,L. Kodach,J. van Sandick, J. van Dieren, S. Balduzzi, M. C. Grootscholten, X. Veenhof, K. Hartemink, M. Vollebergh,

Annals of Oncologyno. 7 (2022): S1106-S1106

引用1浏览0引用

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study

M. Chalabi, Y.L. Verschoor,J. van den Berg, K. Sikorska,G. Beets, A.V. Lent, M.C. Grootscholten, A. Aalbers, N. Buller, H. Marsman, E. Hendriks, P.W.A. Burger,

Annals of Oncology（2022）

引用79浏览0引用

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial